Pneumonia Testing Market to Obtain Awesome Hike in Revenues

Global Pneumonia Testing Market report it provides a vital recent industry data which covers in general market situation along with future scenario for industry around the Globe. It also consists of major data along with forecasts of a global market along with clear presentation of diagrams (charts and tables).

According to a new report published by Allied Market Research, titled, "Pneumonia Testing Market by Method (Immunodiagnostics, Molecular Diagnostics, and Point of Care Testing), Technology (Enzyme Linked Immunosorbent Assay, Immunofluorescence, Western Blot, Polymerase Chain Reaction, Immunohistochemistry, and Others), Type (Analyzers and Consumables), and End User (Hospitals, Diagnostic Laboratories, Homecare, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023"

The pneumonia testing market accounted for $932 million in 2016, and is estimated to reach $1,738 million by 2023, registering a CAGR of 9.2% from 2017 to 2023.

Download PDF Report Sample with statistical info @ https://www.alliedmarketresearch.com/request-sample/3776

Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key companies profiled in the report include Thermo Fisher Scientific Inc., Abbott Laboratories, F-Hoffmann la Roche Ltd., Hologic Inc., bioMerieux, Becton, Dickenson and Company, Bio-Rad Laboratories Inc., Meridian Biosciences, Quest Diagnostics, and Quidel.
Other prominent players in the value chain include AdvanDx, Beckman Coulter, Cepheid, Concile, Diamedix, DiaSorin, Fast-track Diagnostics, SeraCare, and Trinity Biotech.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/3776

Key Benefits
o The study provides an in-depth analysis of the market along with current trends and future estimations to elucidate the imminent investment pockets.
o Extensive analysis of the market is conducted by following key product positioning and monitoring the top competitors within the market framework.
o It offers a quantitative analysis to enable the stakeholders to capitalize on the prevailing market opportunities.
o Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
o Key players are profiled and their strategies are analyzed thoroughly to understand the competitive outlook of the global market.

Pneumonia Testing Market Key Segments:

By Method
o Immunodiagnostics
o Molecular Diagnostics
o Point of Care (POC) Testing

By Technology
o Enzyme-linked Immunosorbent Assay (ELISA)
o Immunofluorescence
o Western Blot
o Polymerase Chain Reaction (PCR)
o Immunohistochemistry (IHC)
o Others

By Type
o Analyzers
o Consumables

By End User
o Hospitals
o Diagnostic Laboratories
o Homecare
o Other

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web:https://www.alliedmarketresearch.com
Follow Us on LinkedIn:https://www.linkedin.com/company/allied-market-research

About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains.

This release was published on openPR.